Vimarsana
Biggest News Aggregation in the World

Applied Nanotechnology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Applied Nanotechnology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Applied Nanotechnology Today - Breaking & Trending Today

SmartID: New Barcode System Allows Users to Check for Counterfeit Medicine via Smartphone - Vimarsana News

SmartID: New Barcode System Allows Users to Check for Counterfeit Medicine via Smartphone

The SmartID system introduces a counterfeit-resistant barcode mechanism to verify the authenticity of a product via a smartphone.

Checking for counterfeit medication using a smartphone - Vimarsana News

Checking for counterfeit medication using a smartphone

Particularly when it comes to medication or medical devices sold online, end-users often wonder whether these are real or fake. The SmartID counterfeit-proof barcode system means anyone can use a smartphone to check a product is genuine, provided the manufacturer uses SmartID. It can be authenticated without connecting to a database. SmartID has been developed by a consortium of Fraunhofer institutes. The result of a three-year project, they will exhibit a demonstration version of their SmartID at the joint Fraunhofer booth (Hall 3, Booth E74) at MEDICA 2023 in Düsseldorf from November 13 to ...

Using barcodes for product authentication - Vimarsana News

Using barcodes for product authentication

Scientists are developing a counterfeit-proof barcode system for authenticity verification that uses a smartphone without the need to access a database.

A gentle, cost-effective method for breast cancer diagnosis - Vimarsana News

A gentle, cost-effective method for breast cancer diagnosis

If breast cancer is suspected, doctors carry out a biopsy. However, this is invasive, painful and costly. It also takes several days to get the results.

Research reveals why a common genetic variant worsens outcomes for people with ALS and FTD - Vimarsana News

Research reveals why a common genetic variant worsens outcomes for people with ALS and FTD

A pioneering new study led by UCL and National Institutes of Health (NIH) scientists has revealed, for the first time, why a common genetic variant worsens disease outcomes for people with the devastating adult-onset neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).